Cartesian Therapeutics Inc (RNAC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 143,384 | 160,324 | 180,434 | 212,610 | 219,198 |
| Receivables | 722 | 354 | 1,765 | 872 | 5,809 |
| TOTAL | $147,260 | $163,395 | $185,120 | $216,626 | $229,136 |
| Non-Current Assets | |||||
| PPE Net | 12,394 | 12,285 | 10,174 | 9,912 | 10,225 |
| Investments And Advances | 2,000 | 2,000 | 2,000 | 2,000 | 2,000 |
| Intangibles | 48,163 | 48,163 | 48,163 | 48,163 | 48,163 |
| Other Non-Current Assets | 162,858 | 163,050 | 163,673 | 158,322 | 165,792 |
| TOTAL | $225,415 | $225,498 | $224,010 | $218,397 | $226,180 |
| Total Assets | $372,675 | $388,893 | $409,130 | $435,023 | $455,316 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,225 | 454 | 2,097 | 288 | 517 |
| Accrued Expenses | 7,702 | 8,012 | 9,197 | 12,076 | 9,452 |
| Other current liabilities | 0 | 0 | 0 | 7,761 | 8,666 |
| TOTAL | $13,803 | $12,256 | $14,998 | $22,976 | $21,405 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 378,575 | 363,023 | 399,780 | 402,708 | 417,306 |
| TOTAL | $394,716 | $379,164 | $415,921 | $418,849 | $433,159 |
| Total Liabilities | $408,519 | $391,420 | $430,919 | $441,825 | $454,564 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 26,004 | 26,002 | 25,954 | 25,907 | 25,415 |
| Common Shares | 3 | 3 | 3 | 3 | 2 |
| Retained earnings | -729,797 | -693,895 | -709,781 | -692,071 | -681,818 |
| Other shareholders' equity | -4,587 | -4,577 | -4,589 | -4,621 | -4,606 |
| TOTAL | $-35,844 | $-2,527 | $-21,789 | $-6,802 | $752 |
| Total Liabilities And Equity | $372,675 | $388,893 | $409,130 | $435,023 | $455,316 |